| 标题 |
Design and Rationale for a Phase II, Randomized, Open-Label, Two-Cohort Multicenter Interventional Study of Osimertinib with or Without Savolitinib in De Novo MET Aberrant, EGFR-Mutant Patients with Advanced Non-Small-Cell Lung Cancer: The FLOWERS Trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Lung Cancer 作者:Anna Li; Hua‐Jun Chen; Jin‐Ji Yang 出版日期:2022-09-30 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)